Vimarsana
Biggest News Aggregation in the World

Page 17 - Technology Commercialization News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Commercialization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Commercialization Today - Breaking & Trending Today

Chemists uses nature as inspiration for a sustainable, affordable adhesive system - Vimarsana News

Chemists uses nature as inspiration for a sustainable, affordable adhesive system

WEST LAFAYETTE — Glue holds the world together. Without adhesives, much of modern human civilization — including our cellphones, cars, furniture, walls and the packages arriving on our doorstep —

Purdue lipid biomarker panels being used to certify beef quality - Vimarsana News

Purdue lipid biomarker panels being used to certify beef quality

Another area of interest is screening for mycotoxins in diverse types of grains.

UK, partners awarded $12 million to advance biomedical innovation, entrepreneurship - Vimarsana News

UK, partners awarded $12 million to advance biomedical innovation, entrepreneurship

The University of Kentucky and its partners at four other institutions have been awarded $12 million from the National Institutes of Health to launch the Mid-South Research Evaluation and Commercialization Hub (REACH).

Source: uky.edu
ZS Instruments Receives $1M Grant to Develop Advanced Lithography Tech for Precision Optical Encoders - Vimarsana News

ZS Instruments Receives $1M Grant to Develop Advanced Lithography Tech for Precision Optical Encoders

A Purdue University-connected startup has received federal funding to innovate an industry projected to reach $4.4 billion by 2028.

Researchers predict prostate cancer recurrence 15 months faster with new model - Vimarsana News

Researchers predict prostate cancer recurrence 15 months faster with new model

New technology developed by Purdue University professor can detect prostate cancer recurrence 14.8 months sooner than existing clinical practices.